Chronic neurological diseases are the leading cause of disability globally. Yet, our health-
care systems are not designed to meet the needs of many patients with chronic neurological …

The natural pattern of progression of Parkinson's disease is largely unknown because
patients are conventionally followed on treatment. As Parkinson's disease progresses, the …

Parkinson's disease (PD) or simply Parkinson's is a long-term degenerative disorder of the
central nervous system, which mainly affects the motor system. Consequently, the detection …

Background The growing burden of Parkinson's disease (PD) in Africa necessitates the
identification of available therapies and services to improve patient care. Objective To …

Background Parkinson's disease (PD) is the second most common neurodegenerative
disorder and, according to the Global Burden of Disease estimates in 2015, was the fastest …

Neurodegenerative conditions are prominent contributors to both morbidity and mortality
worldwide. They pose a significant challenge to health professionals, health systems, and …

The burden of Parkinson's disease (PD) is becoming increasingly important in the context of
an aging African population. Although PD has been extensively investigated with respect to …

Parkinson's disease (PD) is a progressive, disabling, neurodegenerative disease that
requires long term care and pharmaceutical treatment. Levodopa remains the gold standard …

Parkinson's disease (PD) is the second most common neurodegenerative disease globally.
It is a progressive neurological disorder which can lead to a decline in wellbeing and quality …

Very little is known about the experience of people living with Parkinson's disease (PD) in
low-and middle-income countries, such as those in sub-Saharan Africa. The number of …